Organogenesis Holdings (ORGO) EPS (Basic) Growth (5y) (2021 - 2026)
Organogenesis Holdings (ORGO) EPS (Basic) Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Organogenesis Holdings | 239.33 Mn | 192.49 Mn | 20.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -46.66% |
| Mar 31, 2026 | -50.23% |
| Dec 31, 2025 | 14.28% |
| Sep 30, 2025 | -10.50% |
| Jun 30, 2025 | -14.29% |
| Mar 31, 2025 | -1.83% |
| Dec 31, 2024 | 29.26% |
| Sep 30, 2024 | 22.46% |
| Jun 30, 2024 | -3.85% |
| Mar 31, 2024 | 37.93% |
| Dec 31, 2023 | 15.80% |
| Sep 30, 2023 | 15.08% |
| Jun 30, 2023 | 15.10% |
| Mar 31, 2023 | 60.39% |
| Dec 31, 2022 | 16.23% |
| Sep 30, 2022 | 14.90% |
| Jun 30, 2022 | 82.32% |
| Mar 31, 2022 | -15.20% |
| Dec 31, 2021 | 17.40% |
| Sep 30, 2021 | 120.93% |